Consolidating its focus on the diagnostics market, TechneCorp. said Wednesday that it will sell its wholly ownedchemical instrument subsidiary, Hycel S.A., to Lisabio, aFrench instrument firm. Subject to final agreement, Lisabiowill buy all outstanding Hycel stock. Techne (NASDAQ:TECH)will receive $1 million in cash.
On Tuesday, Techne's Minneapolis-based R&D Systemssubsidiary purchased Amgen Inc.'s research reagent and kitdiagnostic businesses for about $4.5 million.
(c) 1997 American Health Consultants. All rights reserved.